Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Japanese Journal of Clinical Oncology|May 7, 2021
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)Nobuhiko Nakamura, Dai Maruyama, Ryunosuke Machida, et al.
Cancer Science|July 22, 2024
Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305)Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, et al.
Japanese Journal of Clinical Oncology|August 30, 2024
Real-world treatment costs of first-line treatment for metastatic colorectal cancer: a survey of the JCOG colorectal cancer study groupAtsuo Takashima, Megumi Ishiguro, Keita Sasaki, et al.
BMC Cancer|March 8, 2023
Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanibMakoto Endo, Tomoko Kataoka, Toshifumi Fujiwara, et al.
Acta Neuropathologica|June 20, 2021
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastomaKenji Fujimoto, Hideyuki Arita, Kaishi Satomi, et al.
Japanese Journal of Clinical Oncology|June 6, 2024
Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021-22Hiroshi Imaoka, Keita Sasaki, Ryunosuke Machida, et al.
Breast Cancer : Basic and Clinical Research|November 4, 2024
Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY StudyMomoko Tokura, Mark Malalay Ando, Yuki Kojima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2025
Methotrexate, Doxorubicin, and Cisplatin Versus Methotrexate, Doxorubicin, and Cisplatin + Ifosfamide in Poor Responders to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma (JCOG0905): A Multicenter, Open-Label, Randomized TrialHiroaki Hiraga, Ryunosuke Machida, Akira Kawai, et al.
Japanese Journal of Clinical Oncology|September 2, 2025
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphomaKen Ohmachi, Tomohiro Kinoshita, Dai Maruyama, et al.
British Journal of Cancer|July 23, 2022
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306Kazuhiro Tanaka, Ryunosuke Machida, Akira Kawai, et al.
Pageof 8